Moffitt logo

Moffitt Notice of Blackbaud Data Incident. Learn More

Clinical Trials Search

Clinical Trial 19209

Cancer Type: Healthy Subjects
Study Type: Screening
NCT#:

Phase: N/A
Prinicipal Investigator: John Heine

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Combined Imaging and Blood Biomarkers for Breast Cancer Diagnosis

Summary

In this study, investigators are analyzing computer measurements from mammograms and combining them with measurements from blood samples to make improved diagnostic decisions. The goal is to eliminate biopsy procedures when they are not required for some women.

Objective

The primary objectives of this project are to: (1) construct a combined repository with mammographic images and biospecimens as an EDRN resource; and (2) perform preliminary analyses to evaluate the possibility that blood analytes combined with automated image measurements can provide adequate performance to eliminate a portion of the negative biopsies while maintaining high sensitivity in a breast screening population restricted to those women designated as a BI-RADS 4.

Treatments

Therapies

Medications

Inclusion Criteria

  • History of ductal carcinoma in situ (DCIS) (>1 year post-diagnosis)
  • History of atypical ductal hyperplasia (ADH)
  • History of Benign Biopsies
  • Cyst Aspiration
  • Complicated Cyst (for pathology)

  • Exclusion Criteria

  • Males
  • > History of invasive breast or other cancer excluding basal/squamous cell skin cancer
  • Already diagnosed for the current breast presentation (cancer or otherwise)
  • Renal Disease and/or Transplant/non cancer
  • Lung Disease and/or Transplant/non cancer
  • Heart Disease and/or Transplant/non cancer

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.